Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 05, 2024, titled "Strides receives USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg".
Strides Pharma Science Limited has informed the Exchange regarding a press release dated March 05, 2024, titled "Strides receives USFDA approval for Gabapentin Tablets USP, 600 mg and 800 mg".